MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4111/icu.20260002

Медицинская библиотека · Investigative and clinical urology · 2026

An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men.

Jung Jae Hung, Han Gong Ho, So Beomgi, Hong Myunghee, Ahn Si Hoon, Lim Sung Hyun, Han Soo Min, Park Hongzoo, Lee Sang Wook, Song Geehyun, Choi Sukjung, Chung Hyun Chul, Chung Hong, Kang Tae Wook, Eom Minseob, Koh Sang Baek, Kim Jeong Hyun

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: Prostate cancer (PCa) is traditionally diagnosed using prostate-specific antigen (PSA)-based testing together with demographic and clinical factors. Building on this framework, we aimed to develop an AI (artificial intelligence) model for prebiopsy PCa diagnosis by integrating Korean population-relevant risk-associated single nucleotide polymorphisms (SNPs) to improve diagnostic accuracy.

MATERIALS AND

METHODS

Three models were developed in this study: Korean PCa-specific genomic score (GenPCa-Kor score), electronic medical record (EMR) meta-model, and Geno-EMR meta-model. From genome-wide association study summary statistics, 1,347 PCa-associated SNPs were selected for a deep neural network to derive the GenPCa-Kor score. Thirteen clinico-laboratory EMR parameters were used to build a stacking ensemble (EMR meta-model) with Light Gradient Boosting Machine, and Histogram-based Gradient Boosting Machine, and logistic regression as base learners and logistic regression as the meta-learner, using 10-fold cross-validation and Bayesian hyperparameter optimization. The Geno-EMR meta-model added the GenPCa-Kor score as a 14th feature to the same architecture.

RESULTS

Of 1,590 systematic biopsy-confirmed participants, 1,006 were analyzed; 757 comprised the training cohort and 249 consecutive patients comprised the independent test cohort. In the training cohort, the EMR meta-model and Geno-EMR meta-model achieved area under curves (AUCs) of 0.868 and 0.924, respectively. In the test cohort, their AUCs were 0.859 and 0.892, respectively. For clinically significant PCa (Grade Group ≥2), the Geno-EMR meta-model further improved the AUC from 0.887 to 0.911.

CONCLUSIONS

The Geno-EMR meta-model that integrate routine clinico-laboratory parameters with the SNP-based GenPCa-Kor score showed improved discrimination for PCa compared with the EMR meta-model alone.

Для цитирования: Jung Jae Hung, Han Gong Ho, So Beomgi, Hong Myunghee, Ahn Si Hoon, Lim Sung Hyun, Han Soo Min, Park Hongzoo, Lee Sang Wook, Song Geehyun, Choi Sukjung, Chung Hyun Chul, Chung Hong, Kang Tae Wook, Eom Minseob, Koh Sang Baek, Kim Jeong Hyun. An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men.. Investigative and clinical urology. 2026. DOI: 10.4111/icu.20260002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.